Antibody – Drug Conjugates (ADC) – Drug Discovery Today: Technologies

Drug Discovery Today: Technologies - United Kingdom
doi 10.1016/j.ddtec.2018.11.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Antibody Drug Conjugates (ADC) Charged With HDAC Inhibitor for Targeted Epigenetic Modulation

Chemical Science
Chemistry
2018English

Antibody-Drug Conjugates in Bladder Cancer

Bladder Cancer
OncologyUrology
2018English

The Promise of Antibody–Drug Conjugates

New England Journal of Medicine
Medicine
2012English

Studies on Antibody-Anticancer Drug Conjugates

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1983English

Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism?

Frontiers in Oncology
Cancer ResearchOncology
2019English

Site-Specific Antibody Drug Conjugates for Cancer Therapy

mAbs
AllergyImmunology
2013English

Bispecifics and Antibody–drug Conjugates: A Positive Synergy

Drug Discovery Today: Technologies
BiotechnologyDrug DiscoveryMolecular Medicine
2018English

Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) Is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

Monodisperse Polysarcosine-Based Highly-Loaded Antibody-Drug Conjugates

Chemical Science
Chemistry
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy